X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (456) 456
Publication (49) 49
Patent (11) 11
Book Chapter (10) 10
Book / eBook (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (213) 213
infectious diseases (129) 129
index medicus (118) 118
clostridium difficile (106) 106
diarrhea (104) 104
microbiology (93) 93
infections (77) 77
male (74) 74
epidemiology (70) 70
female (66) 66
disease (64) 64
immunology (58) 58
adult (55) 55
middle aged (55) 55
aged (54) 54
clostridium difficile - isolation & purification (54) 54
antibiotics (50) 50
infection (50) 50
clostridium difficile - genetics (45) 45
anti-bacterial agents - therapeutic use (44) 44
clostridium difficile - classification (43) 43
animals (42) 42
clostridium infections (39) 39
clostridium infections - microbiology (38) 38
risk factors (37) 37
colitis (35) 35
enterocolitis, pseudomembranous - microbiology (35) 35
hospitals (35) 35
health aspects (34) 34
public, environmental & occupational health (34) 34
vancomycin (33) 33
toxins (32) 32
clostridium difficile - drug effects (31) 31
clostridium difficile - pathogenicity (31) 31
cross infection - microbiology (30) 30
colonization (29) 29
microbial sensitivity tests (29) 29
antimicrobials (28) 28
bacteria (28) 28
feces - microbiology (28) 28
clostridium infections - epidemiology (27) 27
enterocolitis, pseudomembranous - epidemiology (27) 27
medicine, general & internal (27) 27
cross infection - epidemiology (26) 26
diarrhea - microbiology (26) 26
adolescent (25) 25
strain (24) 24
aged, 80 and over (23) 23
nursing (23) 23
outbreak (23) 23
cross infection - prevention & control (22) 22
mortality (22) 22
clostridium infections - drug therapy (21) 21
prevention (21) 21
united states (21) 21
clostridium infections - diagnosis (20) 20
enterocolitis, pseudomembranous - drug therapy (20) 20
recurrence (20) 20
anti-bacterial agents - pharmacology (19) 19
care and treatment (19) 19
clostridium (19) 19
epidemics (19) 19
hamsters (19) 19
health care industry (19) 19
metronidazole (19) 19
research (19) 19
vancomycin - therapeutic use (19) 19
young adult (19) 19
enterocolitis, pseudomembranous - prevention & control (18) 18
pseudomembranous colitis (18) 18
risk (18) 18
clinical trials (17) 17
diagnosis (17) 17
drug resistance, microbial (17) 17
epidemic (17) 17
infection control (17) 17
polymerase chain reaction (17) 17
bacterial typing techniques (16) 16
disease outbreaks (16) 16
enterocolitis, pseudomembranous - diagnosis (16) 16
prospective studies (16) 16
rabbits (16) 16
recommendations (16) 16
retrospective studies (16) 16
surveillance (16) 16
time factors (16) 16
usage (16) 16
virulence (16) 16
analysis (15) 15
bacterial proteins - genetics (15) 15
child, preschool (15) 15
infant (15) 15
risk-factors (15) 15
bacterial toxins - genetics (14) 14
child (14) 14
genotype (14) 14
hygiene (14) 14
incidence (14) 14
pharmacology & pharmacy (14) 14
relapse (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1988, 81-178.
Book
The New England Journal of Medicine, ISSN 0028-4793, 01/2010, Volume 362, Issue 3, pp. 197 - 205
Journal Article
1991, Seminars in respiratory infections, Volume 6, no. 2-3., 2 v.
Book
Clinical Infectious Diseases, ISSN 1058-4838, 02/2019, Volume 68, Issue 4, pp. 699 - 704
Bezlotoxumab, a monoclonal antibody directed against Clostridium difficile toxin B, is the first agent approved for prevention of C. difficile infection... 
STRAINS | INFECTIOUS DISEASES | COST-EFFECTIVENESS | PROTECTION | MECHANISM | Clostridium difficile | PREVENTION | MICROBIOLOGY | IMMUNOLOGY | adjunctive treatment | VIRULENCE | NOSOCOMIAL OUTBREAK | bezlotoxumab | TOLEVAMER | monoclonal antibody | MONOCLONAL-ANTIBODIES | CLOSTRIDIUM-DIFFICILE TOXINS
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 03/2018, Volume 18, Issue 3, pp. 231 - 233
Recurrence rates after fidaxomicin treatment are lowest in EXTEND (4·9%),1 followed by the study by Cornely and colleagues3 (12·7%). [...]the greatest effect... 
INFECTIOUS DISEASES | VANCOMYCIN | FIDAXOMICIN | EFFICACY | HUMAN GUT MODEL | REGIMENS | Fidaxomicin | Vancomycin | Clostridium Infections | Humans | Clostridium difficile | Studies | Prevention | Infections | Antibiotics | Patients
Journal Article
Anaerobe, ISSN 1075-9964, 05/2019, Volume 58, pp. 95 - 102
Current and future management of Clostridioides difficile infection (CDI) including antibiotic treatment is increasingly focused on preventive strategies,... 
Microbiota (Symbiotic organisms) | Monoclonal antibodies | Health aspects
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2018, Volume 67, Issue 11, pp. 1799 - 1800
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 03/2016, Volume 62, Issue 6, pp. 753 - 754
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 07/2015, Volume 62, Issue 6, pp. 753 - 754
Journal Article
JAMA, ISSN 0098-7484, 02/2019, Volume 321, Issue 5, p. 512
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 02/2019, Volume 321, Issue 5, pp. 512 - 513
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.